Rocephin and Rocuronium bromide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rocephin (ceftriaxone sodium) and Rocuronium bromide (rocuronium bromide). Common drug interactions include abdominal pain upper among females and drug rash with eosinophilia and systemic symptoms among males.
The phase IV clinical study analyzes what interactions people have when they take Rocephin and Rocuronium bromide. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.
What is Rocephin?
Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.
What is Rocuronium bromide?
Rocuronium bromide has active ingredients of rocuronium bromide. eHealthMe is studying from 5,615 Rocuronium bromide users. Check the latest studies of Rocuronium bromide.
35 people who take Rocephin and Rocuronium bromide together, and have interactions are studied.

What are the common drug interactions of Rocephin and Rocuronium Bromide, by gender? *:
female:
- Abdominal pain upper
- Fall
- Hepatic enzyme increased
- Hepatic steatosis (fatty liver disease)
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
- Pancreatitis (inflammation of pancreas)
- Post procedural haematoma (post procedural clotting of blood)
- Pruritus (severe itching of the skin)
- Rash
- Vascular pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)
male:
- Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
- Lymphocyte stimulation test positive
- Muscle spasms (muscle contraction)
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
- Constipation
- Cough
- Drug ineffective
- Hypersensitivity
- Pyrexia (fever)
What are the common drug interactions of Rocephin and Rocuronium Bromide, by age (0-1 to 60+)? *:
0-1:
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Hypersensitivity
2-9:
n/a
10-19:
- Drug rash with eosinophilia and systemic symptoms (adverse drug reactions with rash)
- Lymphocyte stimulation test positive
- Constipation
- Pyrexia (fever)
- Streptococcal infection
20-29:
n/a
30-39:
n/a
40-49:
- Cough
- Drug ineffective
50-59:
n/a
60+:
- Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
- Abdominal pain upper
- Hepatic steatosis (fatty liver disease)
- Initial insomnia (feeling of inadequate or poor-quality sleep)
- Muscle spasms (muscle contraction)
- Pancreatitis (inflammation of pancreas)
- Post procedural haematoma (post procedural clotting of blood)
- Pruritus (severe itching of the skin)
- Rash
- Vascular pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)
What are the existing conditions these people have? *
- Fever: 29 people, 82.86%
- Constipation: 27 people, 77.14%
- Pain: 3 people, 8.57%
- Nausea (feeling of having an urge to vomit): 3 people, 8.57%
- Ill-Defined Disorder: 3 people, 8.57%
- Rectal Tenesmus (a feeling of incomplete defecation): 2 people, 5.71%
- Hypersensitivity: 2 people, 5.71%
- Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 5.71%
- High Blood Pressure: 2 people, 5.71%
- Dyspnea (difficult or laboured breathing): 2 people, 5.71%
* Approximation only. Some reports may have incomplete information.
Do you take Rocephin and Rocuronium bromide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Rocephin (15,665 reports)
- Rocuronium bromide (5,615 reports)
Browse all drug interactions of Rocephin and Rocuronium bromide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Rocuronium bromide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rocephin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rocuronium bromide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ceftriaxone sodium and rocuronium bromide (the active ingredients of Rocephin and Rocuronium bromide, respectively), and Rocephin and Rocuronium bromide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Codeine cause Blood Pressure Systolic Decreased? - 4 seconds ago
- Drug interactions of Zide and Serzone - 14 seconds ago
- Could Potassium cause Uterine Haemorrhage? - 14 seconds ago
- Could Celebrex cause Blood Immunoglobulin G Increased? - 18 seconds ago
- Bone Marrow Disorder and drugs of ingredients of albuterol - 19 seconds ago
- Drug interactions of Omega-3 Fatty Acids and Lantus - 20 seconds ago
- Could Omeprazole cause Thyroid Operation? - 26 seconds ago
- Drug interactions of Pulmicort and Ciprofloxacin - 29 seconds ago
- Warfarin Sodium and Guillain-Barre Syndrome for Men aged 50-59 - 31 seconds ago
- Warfarin Sodium and Guillain-Barré Syndrome for Men aged 50-59 - 31 seconds ago